These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 34062264)
61. [Surgery for periampullary pancreatic cancer]. Hank T; Klaiber U; Sahora K; Schindl M; Strobel O Chirurg; 2021 Sep; 92(9):776-787. PubMed ID: 34259884 [TBL] [Abstract][Full Text] [Related]
62. Updates on adjuvant and neoadjuvant treatment strategies for surgically resectable and borderline resectable pancreatic ductal adenocarcinoma. Iyengar S; Nevala-Plagemann C; Garrido-Laguna I Ther Adv Med Oncol; 2021; 13():17588359211045861. PubMed ID: 34552668 [TBL] [Abstract][Full Text] [Related]
63. The role of adjuvant therapy for pancreatic cancer. Magee CJ; Ghaneh P; Hartley M; Sutton R; Neoptolemos JP Expert Opin Investig Drugs; 2002 Jan; 11(1):87-107. PubMed ID: 11772324 [TBL] [Abstract][Full Text] [Related]
64. Minimally invasive image-guided therapy of primary and metastatic pancreatic cancer. Bibok A; Kim DW; Malafa M; Kis B World J Gastroenterol; 2021 Jul; 27(27):4322-4341. PubMed ID: 34366607 [TBL] [Abstract][Full Text] [Related]
65. Clinical Management: Resectable Disease. White RR; Lowy AM Cancer J; 2017; 23(6):343-349. PubMed ID: 29189330 [TBL] [Abstract][Full Text] [Related]
66. Management of pancreatic carcinoma. Hunstad DA; Norton JA Surg Oncol; 1995; 4(2):61-74. PubMed ID: 7551261 [TBL] [Abstract][Full Text] [Related]
67. Adenocarcinoma of the pancreas: the rationale for neoadjuvant therapy. Sperti C; Pasquali C; Pastorelli D; Ferronato A; Decet G; Pedrazzoli S Acta Biomed; 2003; 74 Suppl 2():91-5. PubMed ID: 15055044 [TBL] [Abstract][Full Text] [Related]
68. Imaging-guided curative surgical resection of pancreatic cancer in a xenograft mouse model. Ni X; Yang J; Li M Cancer Lett; 2012 Nov; 324(2):179-85. PubMed ID: 22617626 [TBL] [Abstract][Full Text] [Related]
70. [Cancer of the pancreas]. Buscail L; Bournet B; Cordelier P Bull Acad Natl Med; 2012 Dec; 196(9):1819-27; discussion 1827-8. PubMed ID: 24552104 [TBL] [Abstract][Full Text] [Related]
71. Adjuvant therapy for pancreatic cancer: current status, future directions. Regine WF; Abrams RA Semin Oncol; 2006 Dec; 33(6 Suppl 11):S10-3. PubMed ID: 17178279 [TBL] [Abstract][Full Text] [Related]
72. A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPARC' trial protocol. Holyoake DL; Ward E; Grose D; McIntosh D; Sebag-Montefiore D; Radhakrishna G; Patel N; Silva M; Mukherjee S; Strauss VY; Odondi L; Fokas E; Melcher A; Hawkins MA BMC Cancer; 2016 Sep; 16(1):728. PubMed ID: 27619800 [TBL] [Abstract][Full Text] [Related]
73. Five-Year Actual Overall Survival in Resected Pancreatic Cancer: A Contemporary Single-Institution Experience from a Multidisciplinary Perspective. Picozzi VJ; Oh SY; Edwards A; Mandelson MT; Dorer R; Rocha FG; Alseidi A; Biehl T; Traverso LW; Helton WS; Kozarek RA Ann Surg Oncol; 2017 Jun; 24(6):1722-1730. PubMed ID: 28054192 [TBL] [Abstract][Full Text] [Related]
74. [Progress in clinical research of pancreatic cancer: from "resection" to "cure"]. Shen J; Guo SW; Jin G Zhonghua Wai Ke Za Zhi; 2019 Jan; 57(1):72-77. PubMed ID: 30612395 [TBL] [Abstract][Full Text] [Related]